Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$191.51 - $216.16 $238,621 - $269,335
1,246 Added 2.99%
42,862 $9.09 Million
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $7.58 Million - $8.34 Million
40,413 Added 3359.35%
41,616 $8.01 Million
Q1 2023

May 17, 2023

SELL
$127.59 - $203.08 $8,038 - $12,794
-63 Reduced 4.98%
1,203 $242,000
Q4 2022

Mar 06, 2023

BUY
$117.37 - $139.17 $40,375 - $47,874
344 Added 37.31%
1,266 $162,000
Q3 2022

Nov 02, 2022

BUY
$135.27 - $180.11 $28,136 - $37,462
208 Added 29.13%
922 $126,000
Q2 2022

Aug 12, 2022

SELL
$108.81 - $179.33 $4.9 Million - $8.08 Million
-45,070 Reduced 98.44%
714 $126,000
Q1 2022

May 13, 2022

BUY
$119.61 - $157.85 $1.12 Million - $1.47 Million
9,334 Added 25.61%
45,784 $6.6 Million
Q4 2021

Feb 14, 2022

BUY
$142.57 - $190.86 $1.03 Million - $1.38 Million
7,207 Added 24.65%
36,450 $5.64 Million
Q3 2021

Nov 12, 2021

BUY
$142.45 - $169.82 $4.14 Million - $4.93 Million
29,033 Added 13825.24%
29,243 $4.97 Million
Q2 2021

Aug 10, 2021

SELL
$135.08 - $161.1 $94,691 - $112,931
-701 Reduced 76.95%
210 $32,000
Q1 2021

May 11, 2021

BUY
$137.51 - $190.8 $10,588 - $14,691
77 Added 9.23%
911 $126,000
Q4 2020

Feb 12, 2021

BUY
$164.63 - $211.93 $137,301 - $176,749
834 New
834 $146,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.